73 related articles for article (PubMed ID: 22084431)
1. Leukemic priming of resting NK cells is killer Ig-like receptor independent but requires CD15-mediated CD2 ligation and natural cytotoxicity receptors.
Sabry M; Tsirogianni M; Bakhsh IA; North J; Sivakumaran J; Giannopoulos K; Anderson R; Mackinnon S; Lowdell MW
J Immunol; 2011 Dec; 187(12):6227-34. PubMed ID: 22084431
[TBL] [Abstract][Full Text] [Related]
2. Antibody-dependent cell lysis by NK cells is preserved after sarcoma-induced inhibition of NK cell cytotoxicity.
Pahl JH; Ruslan SE; Kwappenberg KM; van Ostaijen-Ten Dam MM; van Tol MJ; Lankester AC; Schilham MW
Cancer Immunol Immunother; 2013 Jul; 62(7):1235-47. PubMed ID: 23624801
[TBL] [Abstract][Full Text] [Related]
3. Comparative effects of fagaronine, adriamycin and aclacinomycin on K562 cell sensitivity to natural-killer-mediated lysis. Lack of agreement between alteration of transferrin receptor and CD15 antigen expressions and induction of resistance to natural killer.
Benoist H; Comoe L; Joly P; Carpentier Y; Desplaces A; Dufer J
Cancer Immunol Immunother; 1989; 30(5):289-94. PubMed ID: 2624922
[TBL] [Abstract][Full Text] [Related]
4. The inhibition of ADAM17 in cord blood stem cell-derived CD16
Valipour B; Mohammadi SM; Abedelahi A; Charoudeh HN
Hum Immunol; 2024 May; 85(3):110769. PubMed ID: 38429146
[TBL] [Abstract][Full Text] [Related]
5. Immunophenotypic and functional characterization of ex vivo expanded natural killer cells for clinical use in acute lymphoblastic leukemia patients.
Peragine N; Torelli GF; Mariglia P; Pauselli S; Vitale A; Guarini A; Foà R
Cancer Immunol Immunother; 2015 Feb; 64(2):201-11. PubMed ID: 25341808
[TBL] [Abstract][Full Text] [Related]
6. Activation, coactivation, and costimulation of resting human natural killer cells.
Bryceson YT; March ME; Ljunggren HG; Long EO
Immunol Rev; 2006 Dec; 214():73-91. PubMed ID: 17100877
[TBL] [Abstract][Full Text] [Related]
7. Siplizumab Induces NK Cell Fratricide Through Antibody-Dependent Cell-Mediated Cytotoxicity.
Binder C; Sellberg F; Cvetkovski F; Berg S; Berglund E; Berglund D
Front Immunol; 2021; 12():599526. PubMed ID: 33643309
[TBL] [Abstract][Full Text] [Related]
8. Controlling natural killer cell responses: integration of signals for activation and inhibition.
Long EO; Kim HS; Liu D; Peterson ME; Rajagopalan S
Annu Rev Immunol; 2013; 31():227-58. PubMed ID: 23516982
[TBL] [Abstract][Full Text] [Related]
9. Investigating the lysis of small-cell lung cancer cell lines by activated natural killer (NK) cells with a fluorometric assay for NK-cell-mediated cytotoxicity.
Lehmann C; Glass B; Zeis M; Schmitz N; Uharek L
Cancer Immunol Immunother; 1999 Jul; 48(4):209-13. PubMed ID: 10431691
[TBL] [Abstract][Full Text] [Related]
10. Beta1 integrin triggering affects leukemic cell line sensitivity to natural killer cells.
Rubio G; Ferez X; Mora A; Galvez J; Chicano A; Garcia-Peñarrubia P
Cancer Immunol Immunother; 2002 May; 51(3):130-8. PubMed ID: 11941451
[TBL] [Abstract][Full Text] [Related]
11. Genetic modification of primary natural killer cells overcomes inhibitory signals and induces specific killing of leukemic cells.
Imai C; Iwamoto S; Campana D
Blood; 2005 Jul; 106(1):376-83. PubMed ID: 15755898
[TBL] [Abstract][Full Text] [Related]
12. Sensitization of resting T cells to autologous natural-killer-cell-mediated lysis by phytohemagglutinin.
Baraz L; Kotler M; Condiotti R; Nagler A
Cancer Immunol Immunother; 1999 Dec; 48(9):507-16. PubMed ID: 10602888
[TBL] [Abstract][Full Text] [Related]
13. In vitro differentiated plasmacytoid dendritic cells as a tool to induce anti-leukemia activity of natural killer cells.
Díaz-Rodríguez Y; Cordeiro P; Belounis A; Herblot S; Duval M
Cancer Immunol Immunother; 2017 Oct; 66(10):1307-1320. PubMed ID: 28555259
[TBL] [Abstract][Full Text] [Related]
14. CD2 promotes human natural killer cell membrane nanotube formation.
Comerci CJ; Mace EM; Banerjee PP; Orange JS
PLoS One; 2012; 7(10):e47664. PubMed ID: 23112830
[TBL] [Abstract][Full Text] [Related]
15. Nucleosome-dependent escape of tumor cells from natural-killer-mediated lysis: nucleosomes are taken up by target cells and act at a postconjugation level.
Le Lann-Terrisse AD; Fournié GJ; Benoist H
Cancer Immunol Immunother; 1997 Jan; 43(6):337-44. PubMed ID: 9067405
[TBL] [Abstract][Full Text] [Related]
16. Tyrosine kinase pathways modulate tumor susceptibility to natural killer cells.
Bellucci R; Nguyen HN; Martin A; Heinrichs S; Schinzel AC; Hahn WC; Ritz J
J Clin Invest; 2012 Jul; 122(7):2369-83. PubMed ID: 22684105
[TBL] [Abstract][Full Text] [Related]
17. Nano-chemical priming strategy to enhance TGF-β resistance and anti-tumor activity of natural killer cells.
Choi SH; Cho HB; Choi JH; Kim HJ; Jang HJ; Cho S; Maeng E; Park H; Ryu KS; Park KH; Park KS
J Control Release; 2024 Mar; 367():768-778. PubMed ID: 38341178
[TBL] [Abstract][Full Text] [Related]
18. Cryopreservation impairs 3-D migration and cytotoxicity of natural killer cells.
Mark C; Czerwinski T; Roessner S; Mainka A; Hörsch F; Heublein L; Winterl A; Sanokowski S; Richter S; Bauer N; Angelini TE; Schuler G; Fabry B; Voskens CJ
Nat Commun; 2020 Oct; 11(1):5224. PubMed ID: 33067467
[TBL] [Abstract][Full Text] [Related]
19. Molecular definition of the identity and activation of natural killer cells.
Bezman NA; Kim CC; Sun JC; Min-Oo G; Hendricks DW; Kamimura Y; Best JA; Goldrath AW; Lanier LL;
Nat Immunol; 2012 Oct; 13(10):1000-9. PubMed ID: 22902830
[TBL] [Abstract][Full Text] [Related]
20. Functional genomics identifies N-acetyllactosamine extension of complex N-glycans as a mechanism to evade lysis by natural killer cells.
Zhuang X; Woods J; Ji Y; Scheich S; Mo F; Rajagopalan S; Coulibaly ZA; Voss M; Urlaub H; Staudt LM; Pan KT; Long EO
Cell Rep; 2024 Apr; 43(4):114105. PubMed ID: 38619967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
